Publikationen in Zusammenarbeit mit Forschern von University of Milan (26)

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2013

  1. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

2009

  1. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

    Journal of Hypertension, Vol. 27, Núm. 4, pp. 673-679

  2. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document

    Journal of Hypertension, Vol. 27, Núm. 11, pp. 2121-2158

  3. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

2008

  1. Achieving blood pressure goals globally: Five core actions for health-care professionals. A worldwide call to action

    Journal of Human Hypertension, Vol. 22, Núm. 1, pp. 63-70

2007

  1. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

    Journal of Hypertension, Vol. 25, Núm. 9, pp. 1751-1762

  2. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Journal of Hypertension, Vol. 25, Núm. 6, pp. 1105-1187

  3. 2007 Guidelines for the management of arterial hypertension

    European Heart Journal, Vol. 28, Núm. 12, pp. 1462-1536

  4. ESH/ESC 2007 guidelines for the management of arterial hypertension

    Revista Espanola de Cardiologia, Vol. 60, Núm. 9

  5. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial

    Journal of Hypertension, Vol. 25, Núm. 7, pp. 1473-1479

2006

  1. Identification and management of the hypertensive patient with elevated heart rate: Statement of a European Society of Hypertension Consensus Meeting

    Journal of Hypertension, Vol. 24, Núm. 4, pp. 603-610

  2. Targeting hypertension with Valsartan: Lessons learned from the Valsartan/HCTZ versus amlodipine in stage II hypertensive patients (VAST) trial

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 7, Núm. SUPPL. 1

2004

  1. On the importance of estimating renal function for cardiovascular risk assessment

    Journal of Hypertension, Vol. 22, Núm. 9, pp. 1635-1639

2003

  1. Long-Term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors [1] (multiple letters)

    Journal of the American Medical Association

  2. Long-Term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors [1] (multiple letters)

    JAMA

2002

  1. Antihypertensive treatment in patients with type-2 diabetes mellitus: What guidance from recent controlled randomized trials?

    Journal of Hypertension, Vol. 20, Núm. 11, pp. 2099-2110

2001

  1. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study

    Journal of Hypertension, Vol. 19, Núm. 6, pp. 1149-1159

  2. Principal results from the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

    European Heart Journal, Supplement